Tech Company Financing Transactions

OpGen Funding Round

OpGen closed a $23.6 million Series A funding round on 9/12/2007. Investors included CHL Medical Partners, Highland Capital Partners and Versant Ventures.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

708 Quince Orchard Rd.
Gaithersburg, MD 20878
USA

Phone

(301) 869-9683

Website

www.opgen.com

Email Address

[email protected]

Overview

OpGen (NASDAQ: OPGN) is a leading provider of genetic analysis services and systems. The company's proprietary Optical Mapping system (see technology) is used by academic and commercial organizations worldwide for applications including comparative genomics and genome sequence assembly/validation.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Oliver Schacht

        

Chief Financial Officer

Timothy Dec

        

Chief Marketing Officer

Faranak Atrzadeh

        

Chief Operating Officer

Johannes Bacher

        

VP - Bus. Development

Chris Emery

        

VP - Regulatory Affairs

Autumn Collasius

        

Browse more venture capital transactions:

Prev: 9/12/2007: Sermo venture capital transaction
Next: 9/12/2007: HubSpot venture capital transaction

Share this article

News on VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary